Kava-241 reduced periodontal destruction in a collagen antibody primed Porphyromonas gingivalis model of periodontitis.

scientific article published on 26 July 2017

Kava-241 reduced periodontal destruction in a collagen antibody primed Porphyromonas gingivalis model of periodontitis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JCPE.12784
P932PMC publication ID5650496
P698PubMed publication ID28746780

P50authorSalomon AmarQ38326147
Olivier HuckQ59684060
P2093author name stringBin Cai
Jayesh Patel
Jacob Al-Hashemi
James Panek
Abdulsalam Alshammari
P2860cites workPorphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics?Q24655246
Animal models to study host-bacteria interactions involved in periodontitisQ26863436
Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster)Q28544673
Identification and characterization of kava-derived compounds mediating TNF-alpha suppressionQ33470666
Constituents in kava extracts potentially involved in hepatotoxicity: a reviewQ34179570
Proposal for a kava quality standardization code.Q34200446
Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology.Q34470176
Kava consumption and its health effects.Q34586850
TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB.Q35085107
Kava: an overviewQ35555096
Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to PeriodontitisQ36228512
Periodontitis increases rheumatic factor serum levels and citrullinated proteins in gingival tissues and alter cytokine balance in arthritic ratsQ36328094
The use of rodent models to investigate host-bacteria interactions related to periodontal diseasesQ37058550
Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cellsQ37172061
Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone lossQ37421374
Cytokine regulation of immune responses to Porphyromonas gingivalisQ37780271
Does adjunctive antimicrobial therapy reduce the perceived need for periodontal surgery?Q37816540
What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?Q37842638
Surgical and nonsurgical periodontal therapy. Learned and unlearned conceptsQ38097942
Systemic medication and the inflammatory cascadeQ38169806
Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF.Q38600636
Cytokines during periodontal wound healing: potential application for new therapeutic approachQ38761962
Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis.Q38771457
Risk factors in periodontology: a conceptual framework.Q39012939
Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophagesQ39145051
Variable cell responses to P. gingivalis lipopolysaccharideQ39802848
Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivativesQ40319593
Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis InfectionQ40378814
Two complementary methods of assessing periodontal bone level in ratsQ41212610
Assessment of collagen antibody-induced arthritis in BALB/c mice using bioimaging analysis and histopathological examinationQ41387703
RANKL expression in periodontal disease: where does RANKL come from?Q42409559
Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal diseaseQ44090230
Follicular dendritic cell-secreted protein is decreased in experimental periodontitis concurrently with the increase of interleukin-17 expression and the Rankl/Opg mRNA ratio.Q44823696
Inducible nitric oxide synthase (iNOS) in gingival tissues of chronic periodontitis with and without diabetes: immunohistochemistry and RT-PCR studyQ46763936
Prevalence of periodontitis in adults in the United States: 2009 and 2010.Q47203547
COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in ratsQ57219768
Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitisQ82547569
COX-2 is associated with periodontitis in EuropeansQ83002513
Analysis of TNF-α (-308) polymorphism and gingival crevicular fluid TNF-α levels in aggressive and chronic periodontitis: A preliminary reportQ86649789
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectperiodontitisQ520127
Porphyromonas gingivalisQ3214147
P1104number of pages10
P304page(s)1123-1132
P577publication date2017-09-21
P1433published inJournal of Clinical PeriodontologyQ15638559
P1476titleKava-241 reduced periodontal destruction in a collagen antibody primed Porphyromonas gingivalis model of periodontitis
P478volume44

Reverse relations

cites work (P2860)
Q99233987A therapeutic oxygen carrier isolated from Arenicola marina decreased P. gingivalis induced inflammation and tissue destruction
Q64096419Contribution of Statins towards Periodontal Treatment: A Review
Q90045025Identification of a Kavain Analog with Efficient Anti-inflammatory Effects
Q90425113Kavain Reduces Porphyromonas gingivalis-Induced Adipocyte Inflammation: Role of PGC-1α Signaling
Q64121668Proposal for a novel murine model of human periodontitis using and type II collagen antibody injections
Q89143075Reduction of Articular and Systemic Inflammation by Kava-241 in a Porphyromonas gingivalis-Induced Arthritis Murine Model
Q64069168Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications

Search more.